If you are over 35 years old, we hope to offer you some hope that fertility for the mature couple (using their own genetic material) is possible. Obviously there is an end point to the fertility cycle in women, but there are proven natural methods, that can enhance your fertility outcomes significantly.

Our goal is to assist couples reach full term pregnancy and have healthy babies, and to assist further generations the opportunity to have healthy children of their own.
A study by Foresight, the Association for Pre-conceptual healthcare in the United Kingdom shows that couples going through IVF are up to 47% more successful if they used pre-conceptual health care programs such as ours. The same study demonstrated an astounding success rate of 81% of conceptions among couples previously diagnosed as infertile. Among those who conceived there were no miscarriages, no perinatal deaths, no malformations and no newborn admissions to intensive care. Women who participated in the study were between 25 and 45 years old and Men between 25 and 59 years old .

We will assist in reducing the biological age of the 'egg' and 'sperm' using very specific natural methods and pathology markers of assessment as evidence of change.
There is undisputed evidence that age is the single mostimportant factor in determining the success of assisted reproductive technology (ART). The success of ART begins to decline after the age of 33 and shows a significant decline after the age of 37 with a marked decrease for women over the age of 40 years.
The average 40-year-old has only a 20% chance of achieving a successful pregnancy through IVF using her own eggs and by 45 this is down to only 1-2%
We will support 'poor IVF responders' by increasing number of mature follicles, adequate oestrogen levels, improve ovarian response and endometrial receptivity and consequently pregnancy rates, using proven natural methods.
You chances of IVF success rate reduces dramatically after each cycle and frozen embryo transfers have lower success rates than fresh embryo transfers.
Each IVF stimulation cycle will send a mature woman closer to menopause. Preparation for your IVF should be part of the program, so you have every opportunity for success.
We will aim to reduce rates of miscarriage, recurrent miscarriage and protect the DNA (genetic material) of both the egg and sperm against the aging effects of oxidative stress.
Miscarriage rates, foetal abnormality and perinatal morbidity also appeared higher in women older than 40 years. A growing body of evidence is also indicating an association between autism and older motherhood with one recent study finding that a 40-year-old woman's risk of having a child later diagnosed with autism was 50% greater than that of a woman between 25 and 29.
Australian Government Assisted Reproductive Technologies Review 2006 Australian Institute of Health and Welfare; Australia's mothers and babies 2003. Sydney. AIHW National Perinatal Statistics Unit. Sydney, 2005; Shelton J, et al. Independent and dependent contributions of advanced maternal and paternal ages for autism risk. Autism Research 2010; 3:30-39.
It is imperative you do ALL you can to maximise your chances of conception.


We will commit to do ALL we can to help you on this journey to succeed in having a healthy baby. However, we have criteria for couples who enter this program with us. As we spend countless hours researching your case, you will need to commit to the personal adjustments, dietary modifications, medicine requirements, and lifestyle changes we require of you.
Some ART statistics debunked:
Assisted Reproductive Technologies (ART) Review from 2006 estimates of ART effectiveness may vary according to the definitions of treatment success and the treated population. Live birth rates provide the most clinically relevant measure of ART success. Other outcomes commonly reported in the literature include the rates of fertilisation implantation and pregnancy. Pregnancy may be defined from as loose as a mere pathology test occurrence of an elevated human chorionic gonadotrophin (hCG) concentration; to the occurrence of a clinical pregnancy; or the presence of an on-going pregnancy beyond 20 weeks. These intermediate outcomes do not, however, represent the desired outcome of a healthy live birth.